*  Dyslipidemia Induces Opposing Effects on Intrapulmonary and Extrapulmonary Host Defense through Divergent TLR Response...
Dyslipidemia attenuates induced trafficking of PMNs to the inflamed airspace. To determine the effect of dyslipidemia upon ... Dyslipidemia enhances PMN influx into and host defense within the peritoneum. To address whether dyslipidemia globally impairs ... We hypothesized that dyslipidemia would modify pulmonary innate immunity. In this paper, we report that dyslipidemia attenuates ... The lung has not been widely conceived of as an organ sensitive to systemic dyslipidemia. We report that dyslipidemia regulates ...
  http://www.jimmunol.org/content/185/3/1660.long
*  Dyslipidemia | Lipid Disorders - Levels, Symptoms, Signs, Diagnosis, Treatment and Prevention
Find out more about dyslipidemia, its causes and methods to treat the condition. ... Dyslipidemia is a condition due to imbalance of fats in blood. ... How do you Treat Dyslipidemia?. The treatment of Dyslipidemia ... How to Prevent Dyslipidemia?. It is important to take steps to prevent Dyslipidemia as it is a means of lowering the risk for a ... What are the Causes for Dyslipidemia?. There are many factors for Dyslipidemia and they include:. *Genetic or Hereditary ...
  http://www.medindia.net/patients/patientinfo/dyslipidemia.htm
*  Dyslipidemia Induces Opposing Effects on Intrapulmonary and Extrapulmonary Host Defense through Divergent TLR Response...
... responses to LPS and Klebsiella pneumoniae were investigated using murine models of dyslipidemia. Dyslipidemia reduced ... in which cholesterol was maintained constant during dyslipidemia, had normal responses and rafts. Dyslipidemia thus imparts ... To define whether dyslipidemia impacts responses to bacteria in the airspace and, if so, whether differently from its effects ... Dyslipidemia influences innate immune responses in the bloodstream, but whether and how pulmonary innate immunity is sensitive ...
  http://www.jimmunol.org/content/early/2010/06/25/jimmunol.0903501
*  Dyslipidemia - Wikipedia
Dyslipidemia is an abnormal amount of lipids (e.g. triglycerides, cholesterol and/or fat phospholipids) in the blood. In ... Chou, R; Dana, T; Blazina, I; Daeges, M; Bougatsos, C; Jeanne, TL (18 October 2016). "Screening for Dyslipidemia in Younger ... Prolonged elevation of insulin levels can also lead to dyslipidemia. Likewise, increased levels of O-GlcNAc transferase (OGT) ... may cause dyslipidemia.[citation needed] Physicians and basic researchers classify dyslipidemias in two distinct ways: ...
  https://en.wikipedia.org/wiki/Dyslipidemia
*  Diabetic Dyslipidemia | Diabetes Care
Hiroshi Itoh, Issei Komuro, Masahiro Takeuchi, Takashi Akasaka, Hiroyuki Daida, Yoshiki Egashira, Hideo Fujita, Jitsuo Higaki, Ken-ichi Hirata, Shun Ishibashi, Takaaki Isshiki, Sadayoshi Ito, Atsunori Kashiwagi, Satoshi Kato, Kazuo Kitagawa, Masafumi Kitakaze, Takanari Kitazono, Masahiko Kurabayashi, Katsumi Miyauchi, Tomoaki Murakami, Toyoaki Murohara, Koichi Node, Susumu Ogawa, Yoshihiko Saito, Yoshihiko Seino, Takashi Shigeeda, Shunya Shindo, Masahiro Sugawara, Seigo Sugiyama, Yasuo Terauchi, Hiroyuki Tsutsui, Kenji Ueshima, Kazunori Utsunomiya, Masakazu Yamagishi, Tsutomu Yamazaki, Shoei Yo, Koutaro Yokote, Kiyoshi Yoshida, Michihiro Yoshimura, Nagahisa Yoshimura, Kazuwa Nakao, Ryozo Nagai ...
  http://care.diabetesjournals.org/collection/diabetic-dyslipidemia
*  Secondary causes of dyslipidemia
The secondary causes of dyslipidemia will be reviewed briefly here ().Primary lipid disorders are discussed separately ... Dyslipidemia due to secondary causes is common. In a cohort of 824 new patients referred to a lipid clinic at an academic ... Secondary causes of dyslipidemia. Am J Cardiol 2012; 110:823.. *Zavaroni I, Dall'Aglio E, Alpi O, et al. Evidence for an ... Secondary causes of dyslipidemia. Author. Robert S Rosenson, MD. Robert S Rosenson, MD ...
  https://www.uptodate.com/contents/secondary-causes-of-dyslipidemia
*  Plus it
This article provides a framework for diagnosing and managing dyslipidaemia, with the aim of reducing patients' CVD risk. ... Patients may require consideration of dyslipidaemia and cardiovascular risk for a number of reasons, including pre-existing ... Dyslipidaemia and cardiovascular risk. BMJ 2018; 360 doi: https://doi.org/10.1136/bmj.k835 (Published 23 March 2018) Cite this ...
  https://www.bmj.com/content/360/bmj.k835
*  Combination Therapy In Dyslipidemia | Maciej Banach | Springer
... this book presents the latest and most comprehensive knowledge on the different options for combination therapy of dyslipidemia ... Combination Therapy In Dyslipidemia. Editors. * Maciej Banach Copyright. 2015. Publisher. ADIS. Copyright Holder. Springer ... Dyslipidemia is a leading cause of cardiovascular morbidity and mortality and most patients with this condition fail to achieve ... Addresses a gap left by the latest dyslipidemia management guidelines *Current and comprehensive discussion of options for ...
  https://www.springer.com/us/book/9783319204321
*  Controlled US studies of fenofibrate in the treatment of dyslipidemias | SpringerLink
Blane G.F. (1990) Controlled US studies of fenofibrate in the treatment of dyslipidemias. In: Descovich G., Gaddi A., Magri G ...
  https://link.springer.com/chapter/10.1007/978-94-009-0731-7_59
*  List of Dyslipidemia Medications (5 Compared) - Drugs.com
Compare risks and benefits of common medications used for Dyslipidemia. Find the most popular drugs, view ratings, user reviews ... About Dyslipidemia: Dyslipidemia occurs when the lipid levels in the blood are abnormally high or low. It is mostly the ... Drugs Used to Treat Dyslipidemia. The following list of medications are in some way related to, or used in the treatment of ... Dyslipidemia can be an increase in either low-density lipoproteins, plasma cholesterol, triglycerides, or an… Read more ...
  https://www.drugs.com/condition/dyslipidemia.html
*  Causes and Natural History of Dyslipidemias - Full Text View - ClinicalTrials.gov
Causes and Natural History of Dyslipidemias. The safety and scientific validity of this study is the responsibility of the ... This study will evaluate people with dyslipidemias - disorders that affect the fat content in the blood. Fats, or lipids, such ... will benefit this population of patients since it will facilitate the accurate diagnosis and treatment of their dyslipidemia. ...
  https://clinicaltrials.gov/ct2/show/NCT00353782?cond=%22familial+HDL+deficiency%22+OR+%22Hypoalphalipoproteinemias%22&rank=11
*  Plus it
Insulin Resistance, Dyslipidemia, and Cardiovascular Disease Message Subject (Your Name) has forwarded a page to you from ... Insulin resistance and dyslipidemia. Ronald Krauss (San Francisco, CA) gave insights in the genetics of the more common forms ... Krauss RM: Dietary and genetic probes of atherogenic dyslipidemia. Arterioscler Thromb Vasc Biol 25:2265-2272, 2005. ... There is an intimate relationship between diet and dyslipidemia, and dietary manipulations may be used to understand the ...
  http://care.diabetesjournals.org/content/30/8/2164
*  The Johns Hopkins Textbook of Dyslipidemia | Circulation
Management of dyslipidemia has become a mainstay of routine clinical practice for both hospital specialists and those involved ... A problem with the book is the relatively small section devoted to a discussion of the drug treatment of dyslipidemia. Chapter ... The Johns Hopkins Textbook of Dyslipidemia 303 pages. Philadelphia, USA: Lippincott Willams and Wilkins, 2010. $99.95. ISBN 0- ... Textbooks in the area of dyslipidemia tend to be of 2 main types: relatively brief handbooks that focus on clinical management ...
  http://circ.ahajournals.org/content/122/20/e517
*  Causes and Natural History of Dyslipidemias - No Study Results Posted - ClinicalTrials.gov
Causes and Natural History of Dyslipidemias. The safety and scientific validity of this study is the responsibility of the ...
  https://clinicaltrials.gov/ct2/show/results/NCT00353782
*  Quiz: Dyslipidemia - Merck Manuals Professional Edition
Merck & Co., Inc., Kenilworth, NJ, USA is a global healthcare leader working to help the world be well. From developing new therapies that treat and prevent disease to helping people in need, we are committed to improving health and well-being around the world. The Merck Manual was first published in 1899 as a service to the community. The legacy of this great resource continues as the Merck Manual in the US and Canada and the MSD Manual in the remainder of the world. Learn more about our commitment to Global Medical Knowledge.. ...
  http://www.merckmanuals.com/en-ca/professional/multimedia/quiz/17
*  Genetic Markers Associated to Dyslipidemia in HIV-Infected Individuals on HAART
E. R. Feeney and P. W. G. Mallon, "HIV and HAART-associated dyslipidemia," The Open Cardiovascular Medicine Journal, vol. 5, pp ... Genetic Markers Associated to Dyslipidemia in HIV-Infected Individuals on HAART. Rosmeri K. Lazzaretti,1 Aline S. Gasparotto,2 ... S. Kathiresan, C. J. Willer, G. M. Peloso et al., "Common variants at 30 loci contribute to polygenic dyslipidemia," Nature ... M. P. Dubé, J. H. Stein, J. A. Aberg et al., "Guidelines for the evaluation and management of dyslipidemia in human ...
  https://www.hindawi.com/journals/tswj/2013/608415/ref/
*  K/DOQI To Examine Dyslipidemias In Transplant Patients - The National Kidney Foundation
... professionals will conduct an extensive structured review of the literature related to cardiovascular disease and dyslipidemias ... The relationship between dyslipidemias and cardiovascular disease has been best studied in kidney transplant recipients. ... The effort will encompass recommendations on hypertension, left ventricular hypertrophy and dyslipidemias. ... professionals will conduct an extensive structured review of the literature related to cardiovascular disease and dyslipidemias ...
  https://www.kidney.org/news/newsroom/newsreleases/0172
*  South African Dyslipidaemia Guideline Consensus Statement
8. Management of dyslipidaemia. Because the total cardiovascular risk is the product of a number of risk factors, the treatment ... Dyslipidaemia may occur in response to another condition or treatment. Table 2 lists those encountered most commonly. The ... Dyslipidaemia frequently accompanies HIV and may be aggravated by ARVs. While there is limited information, particularly in ... Intensive management of dyslipidaemia in South Africa will significantly reduce the cardiovascular disease health burden. ...
  http://www.scielo.org.za/scielo.php?script=sci_arttext&pid=S0256-95742012000300032&lng=en&nrm=iso&tlng=en
*  South African Dyslipidaemia Guideline Consensus Statement
... SAMJ, S. Afr. med. j. [online]. 2012, vol.102, n.3, pp.177-187. ISSN ... Intensive management of dyslipidaemia in South Africa will significantly reduce the cardiovascular disease health burden. ... The European Society of Cardiology together with the European Atherosclerosis Society published updated dyslipidaemia ...
  http://www.scielo.org.za/scielo.php?script=sci_abstract&pid=S0256-95742012000300032&lng=es&nrm=iso&tlng=en
*  Sociodemographic, anthropometric and dietary determinants of dyslipidemia in preschoolers
The determinants of dyslipidemia were examined using Poisson regression analysis.. RESULTS: The prevalence of dyslipidemia in ... The prevalence of dyslipidemia in children and adolescents has been high in most countries. According to Al-Shehri,3 ... Dyslipidemia is a disorder of lipoprotein metabolism that results in elevation of plasma lipid levels, such as high total ... The determinants of dyslipidemia identified in this study were less frequent consumption of foods in the 'mixed diet' dietary ...
  http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0021-75572013000500008&lng=en&tlng=en
*  Prevalence of Dyslipidemia in Patients Receiving Health Checkups: A Hospital-Based Study
Prevalence of Dyslipidemia in Patients Receiving Health Checkups: A Hospital-Based Study. Kao-Chi Cheng,1,2 Yu-Lung Chen,1,2 ... That is, the prevalence of dyslipidemia in women is lower in the group aged 20-39 than in the group aged 40 and over, but no ... K. Tziomalos, V. G. Athyros, A. Karagiannis, and D. P. Mikhailidis, "Dyslipidemia as a risk factor for ischemic stroke," ... We used the dataset from one medical center in Taiwan to explore the prevalence of dyslipidemia, which included 2695 subjects ...
  https://www.hindawi.com/journals/cholesterol/2011/314234/
*  Dyslipidemia is common after spinal cord injury - independent of clinical measures
... Flank, Peter Umeå University, Faculty of ... Results: Eighty-one percent of all patients had dyslipidemia (DL) and a majority of the patients with abdominal measures below ... Eighty-one percent of the patients had dyslipidemia, where also a majority of the patients with normal abdominal clinical ... Dyslipidemia was common for both men and women at all BMI categories. The study also showed a high prevalence of hypertension, ...
  http://www.diva-portal.org/smash/record.jsf?pid=diva2:913733
*  Effects of a multicomponent wellness intervention on dyslipidemia among overweight adolescents | RTI
... and strength training on dyslipidemia in nine overweight/obese [body mass index (BMI) ,= 85th percentile] and nine lean (BMI ... Behavioral changes are the first line of treatment for dyslipidemia in adolescents, but outcome data on the effectiveness of ... Behavioral changes are the first line of treatment for dyslipidemia in adolescents, but outcome data on the effectiveness of ... and strength training on dyslipidemia in nine overweight/obese [body mass index (BMI) ,= 85th percentile] and nine lean (BMI , ...
  https://www.rti.org/publication/effects-multicomponent-wellness-intervention-dyslipidemia-among-overweight-adolescents
*  Dyslipidemia Study Investigating The Increase In 'Good Cholesterol' - Full Text View - ClinicalTrials.gov
Dyslipidemia Study Investigating The Increase In 'Good Cholesterol'. The safety and scientific validity of this study is the ... Dyslipidemias. Lipid Metabolism Disorders. Metabolic Diseases. Fenofibrate. Hypolipidemic Agents. Antimetabolites. Molecular ...
  https://clinicaltrials.gov/ct2/show/NCT00169559